May 17, 2015
1155 Recent Articles
May 08, 2015
Board Clarifies When Expanded Panel Can Consider an IPR Issue
April 24, 2015
“Indirect” Common Inventorship Not Sufficient To Support Priority Claim Under 35 U.S.C. §120
April 22, 2015
Strategies for Pharma Companies Facing Bass-Like Challenges in IPR Proceedings
April 20, 2015
30 Months of IPR Practice – By the Numbers
April 15, 2015
Live Testimony for Fact Witness Can Be Appropriate at IPR Oral Hearing
April 13, 2015
Toward a Bullet-Proof Petition – Motivation to Combine
April 10, 2015
Which Party Should File Motion to Seal in Inter Partes Review?
April 08, 2015
Pharmaceutical Filings on the Upswing as Power of IPR Becomes More Well-Known
April 06, 2015
Timing Is Everything When It Comes To Interlocutory Appeals of CBMR-Related Motions To Stay
April 03, 2015
IPR Incorporation by Reference Argument Not Enough to Save Priority Claim
April 02, 2015
Another IPR Victory for Harness IP – Defeat All Challenged Claims of 3 Patents
April 01, 2015
PTO Previews Changes to Inter Partes Review Practice
March 26, 2015
Board Discusses Difference Between Supplemental Evidence and Information
March 25, 2015
PTAB Rules Lab Notebooks Insufficient to Prove Conception and Reduction to Practice
March 24, 2015
PTAB Rejects Two Attempts by Patent Owners to Antedate Prior Art
March 23, 2015
PTAB Declines to Limit Claim Based on Disclosure of Only One Embodiment
March 12, 2015
Teaching Away Arguments Fail to Gain Traction with PTAB
March 09, 2015
Board Disallows Later IPR Petition Directed at Previously-Challenged Patent
March 06, 2015